Twist Bioscience Corp (FRA:0ME)
€ 39.22 -1.36 (-3.35%) Market Cap: 2.23 Bil Enterprise Value: 2.04 Bil PE Ratio: 0 PB Ratio: 4.90 GF Score: 83/100

Twist Bioscience Corp at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 10, 2022 / 09:30PM GMT
Release Date Price: €65.62
Noah James Burhance
JPMorgan Chase & Co, Research Division - Research Analyst

Good afternoon, everybody. I'm [Noah Burhance] of Tycho Peterson's Life Science team. It's my pleasure to introduce our next company, Twist. Just a quick reminder. If you have any questions, feel free to submit them on the website.

And with that, I'll turn it over to Emily.

Emily Marine Leproust
Twist Bioscience Corporation - Co-Founder, Chairman, President & CEO

Thank you, Noah, for the introduction. It's a great pleasure to be here. So a [standard thing] that I will be making some forward-looking statements today. And today, I'll talk about 3 things. One is a quick reminder of our vision, how we executed that vision, and how we are setting up the company for success with multiple revenue streams.

So first, DNA is reinventing many different industry and markets from fragrance to cancer treatment, all the way to the preservation of cultural data with new storage capabilities. And at Twist, we write in a [different fashion]. Our customers use our DNA to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot